A Clinical Trial Comparing Intra Vaginal Misoprostol (PGE1) And Intra Cervical Dinoprostone ( Pge2 ) For Cervical Ripening
Article
| IMSEAR
| ID: sea-184766
ABSTRACT
In the present trial, Misoprostol(PGE1) and Dinoprostone(PGE2) are compared for their efficacy in pre - induction cervical ripening. After informed consent, 100 patients were randomized to receive either Dinoprostone gel int0.5mg inracervically or Misoprostol tablet 25 mcg intravginally. After 8 hrs, change in Bishops score recorded. During the study it is found that, change in Bishops score is significantly more and induction to delivery interval is significantly less in Misoprostol group. The incidence of side effects is similar in both the groups. It is concluded that a single dose of intravaginal Misoprostol is an efficacious, convenient and inexpensive medication for ripening the unfavourable cervix.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Type of study:
Controlled clinical trial
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS